Clonal spread of group A Streptococcus with the new type of erythromycin resistance

被引:75
作者
Kataja, J
Huovinen, P
Muotiala, A
Vuopio-Varkila, J
Efstratiou, A
Hallas, G
Seppälä, H
机构
[1] Natl Publ Hlth Inst, Antimicrobial Res Lab, FIN-20521 Turku, Finland
[2] Natl Publ Hlth Inst, Dept Bacteriol, Helsinki, Finland
[3] Cent Publ Hlth Lab, System Infect Lab, London NW9 5HT, England
关键词
D O I
10.1086/517809
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 1990, a new type of erythromycin resistance phenotype, designated NR, was found in group A streptococcus (GAS) in Finland. In the present study, the distribution of GAS isolates with this and other erythromycin-resistance phenotypes was surveyed in Finland, and the clonality of the isolates was explored, Of 4179 GAS isolates collected from all over Finland, 695 (17%) were resistant to erythromycin, and 82% of these had the NR phenotype. Of a group of 96 isolates with the NR phenotype from different areas, 91% was T4 serotype, opacity factor-positive. The majority of these isolates were studied further: All were M4 serotype and 88% were of one clonal origin in genetic analyses. Thus, one single clone predominates among erythromycin-resistant GAS in Finland. This clone is of T4M4 serotype and mediates the new type of erythromycin resistance, characterized by the NR phenotype.
引用
收藏
页码:786 / 789
页数:4
相关论文
共 15 条
  • [1] GROUP-A STREPTOCOCCAL INFECTIONS AND ACUTE RHEUMATIC-FEVER
    BISNO, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (11) : 783 - 793
  • [2] Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes
    Clancy, J
    Petitpas, J
    DibHajj, F
    Yuan, W
    Cronan, M
    Kamath, AV
    Bergeron, J
    Retsema, JA
    [J]. MOLECULAR MICROBIOLOGY, 1996, 22 (05) : 867 - 879
  • [3] KAUFHOLD A, 1994, FEMS MICROBIOL LETT, V119, P19
  • [4] BACTERIAL-RESISTANCE TO MACROLIDE, LINCOSAMIDE, AND STREPTOGRAMIN ANTIBIOTICS BY TARGET MODIFICATION
    LECLERCQ, R
    COURVALIN, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1267 - 1272
  • [5] USE OF SERUM OPACITY REACTION IN TYPING OF GROUP-A STREPTOCOCCI
    MAXTED, WR
    WIDDOWSON, JP
    FRASER, CAM
    BALL, LC
    BASSETT, DCJ
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1973, 6 (01) : 83 - 90
  • [6] MOODY M D, 1965, Health Lab Sci, V2, P149
  • [7] ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PYOGENES
    PHILLIPS, G
    PARRATT, D
    ORANGE, GV
    HARPER, I
    MCEWAN, H
    YOUNG, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (04) : 723 - 724
  • [8] PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213
  • [9] SEPPALA H, 1994, J CLIN MICROBIOL, V32, P1945
  • [10] 3 DIFFERENT PHENOTYPES OF ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PYOGENES IN FINLAND
    SEPPALA, H
    NISSINEN, A
    YU, Q
    HUOVINEN, P
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (06) : 885 - 891